Inhibition of the BGR-ABL tyrosine kinase for the treatment of chronic myeloid leukemia

被引：0
|
作者：
Coulombel, L [1 ]
机构：
[1] INSERM U474, F-75014 Paris, France
来源：
M S-MEDECINE SCIENCES | 2001年 / 17卷 / 8-9期
关键词：
D O I：
10.4267/10608/2038
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：952 / 953
页数：2
相关论文
共 50 条
  • [1] BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
    Cuellar, Sandra
    Vozniak, Michael
    Rhodes, Jill
    Forcello, Nicholas
    Olszta, Daniel
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 433 - 452
  • [2] Bosutinib: a SRC-ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
    El Rassi, Fuad
    Khoury, Hanna Jean
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2013, 6 : 57 - 62
  • [3] ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia treatment resistance
    Vacarean-Trandafir, Irina Cezara
    Ivanov, Iuliu Cristian
    Dragos, Loredana Mihaiela
    Dascalescu, Angela Smaranda
    Titieanu, Amalia Andrea
    Cojocaru, Dumitru
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (04) : 3747 - 3754
  • [4] Imatinib Mesilate -: Treatment of chronic myeloid leukemia Brc-Abl tyrosine kinase inhibitor
    de Bree, F
    Sorbera, LA
    Fernández, R
    Castañer, J
    DRUGS OF THE FUTURE, 2001, 26 (06) : 545 - 552
  • [5] Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
    Malik, Sara
    Hassan, Shahzeb
    Eskazan, Ahmet Emre
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (11) : 975 - 978
  • [6] BAFETINIB Dual BCR/ABL and Lyn Tyrosine Kinase Inhibitor Treatment of Chronic Myeloid Leukemia
    Takeuchi, M.
    Kimura, S.
    Ashihara, E.
    Maekawa, T.
    DRUGS OF THE FUTURE, 2009, 34 (04) : 261 - 269
  • [7] ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia treatment resistance
    Irina Cezara Vacarean-Trandafir
    Iuliu Cristian Ivanov
    Loredana Mihaiela Dragos
    Angela Smaranda Dascalescu
    Amalia Andrea Titieanu
    Dumitru Cojocaru
    Molecular Biology Reports, 2019, 46 : 3747 - 3754
  • [8] Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
    Tolomeo, Manlio
    Dieli, Francesco
    Gebbia, Nicola
    Simoni, Daniele
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (08) : 853 - 863
  • [9] Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Goldman, JM
    Melo, JV
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14): : 1084 - 1086
  • [10] Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors
    Patel, Ami B.
    O'Hare, Thomas
    Deininger, Michael W.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (04) : 589 - +
12345